SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Biogen Pharmachem Industries informs about updates

01 Apr 2026 Evaluate
Biogen Pharmachem Industries has informed that the Company has fixed Friday, 15th May 2026 as the ‘Record Date’, for the purpose of ascertaining the eligibility of shareholders entitled for issuance of Bonus Equity Shares of the Company in the proportion of 1:6 i.e. 1 (One) new equity shares of Rs 1 each for every 6 (Six) existing equity shares of Rs 1 each fully paid up, subject to the approval of shareholders which is being obtained through Postal Ballot (including e-voting) in accordance with the applicable laws and regulations. The above information will also be made available on the website of the Company: www.biogenpharma.bar.

The above information is a part of company’s filings submitted to BSE.

Biogen Pharmachem Share Price

0.46 -0.01 (-2.13%)
05-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 218.65
Adani Enterprises 2463.55
Amrapali Industries 17.95
Rashi Peripheral 501.50
PDS 277.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×